Celgene Corporation
(NASDAQ : CELG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$838.74m
AMGNAmgen Inc.
0.89%188.341.2%$621.82m
GILDGilead Sciences, Inc.
1.84%67.590.9%$512.40m
BIIBBiogen Inc.
2.51%332.871.3%$445.54m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$305.14m
ILMNIllumina, Inc.
2.51%299.823.5%$302.67m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.75m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$233.68m
LOXOLoxo Oncology Inc
-0.03%234.6612.7%$170.39m
SRPTSarepta Therapeutics, Inc.
2.65%138.4515.4%$148.57m
AAgilent Technologies, Inc.
1.64%78.281.6%$133.87m
INCYIncyte Corporation
0.88%84.152.5%$132.72m
EXASExact Sciences Corporation
0.49%88.5525.3%$128.36m
ARRYArray BioPharma Inc.
4.95%23.138.2%$105.79m
EXELExelixis, Inc.
-0.18%22.266.4%$97.74m

Company Profile

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.